Munich - Delayed Quote EUR
Glass House Brands Inc (4KF0.MU)
4.3200
0.0000
(0.00%)
At close: April 25 at 8:04:35 AM GMT+2
Loading Chart for 4KF0.MU
- Previous Close
4.3200 - Open
4.3200 - Bid 5.4500 x --
- Ask 6.0500 x --
- Day's Range
4.3200 - 4.3200 - 52 Week Range
4.3200 - 8.6000 - Volume
0 - Avg. Volume
15 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 4KF0.MU
View MorePerformance Overview: 4KF0.MU
Trailing total returns as of 4/26/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
4KF0.MU
20.73%
MSCI WORLD (^990100-USD-STRD)
2.41%
1-Year Return
4KF0.MU
48.57%
MSCI WORLD (^990100-USD-STRD)
8.50%
3-Year Return
4KF0.MU
46.00%
MSCI WORLD (^990100-USD-STRD)
28.73%
5-Year Return
4KF0.MU
46.00%
MSCI WORLD (^990100-USD-STRD)
0.00%
Compare To: 4KF0.MU
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.3200
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.2200
+15.79%
Mkt Cap EUR 74.529M
Industry Drug Manufacturers—Specialty & Generic
0.4375
+13.49%
Mkt Cap EUR 436.133M
Industry Drug Manufacturers—Specialty & Generic
0.6720
+21.96%
Mkt Cap EUR 243.989M
Industry Drug Manufacturers—Specialty & Generic
0.1200
0.00%
Mkt Cap CAD -
Industry Drug Manufacturers—Specialty & Generic
1.3920
+26.78%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4404
+12.20%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
5.29
+15.09%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4303
+8.42%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.3320
+24.34%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
Statistics: 4KF0.MU
View MoreValuation Measures
As of 4/25/2025
Market Cap
442.22M
Enterprise Value
473.37M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.83
Price/Book (mrq)
3.25
Enterprise Value/Revenue
2.67
Enterprise Value/EBITDA
15.13
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--